Md. Thomas et al., Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy, INT J RAD O, 47(4), 2000, pp. 905-908
Citations number
7
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: Larger prostate gland volumes have been associated with long-term
urinary morbidity in prostate interstitial radiation therapy utilizing ultr
asound image guidance technique. This study was performed to identify the c
linical and technical predictors of acute urinary retention following magne
tic-resonance (MR)-guided prostate interstitial brachytherapy.
Methods and Materials: Fifty patients underwent MR-guided prostate brachyth
erapy between December 1997 and March 1999. Patient selection was limited t
o men with stage T1cNXM0 disease, PSA of less than 10 ng/mL, biopsy Gleason
score not more than 3 + 4, and endorectal coil MR stage T2 disease. Dosime
try plans were developed in the operating room and (125)Iodine sources were
implanted using MR real-time guidance. The peripheral zone (PZ) of the pro
state gland was defined as the clinical target volume (CTV) and the minimum
prescribed dose to the CTV was 137 Gy. The volumes of the PZ, transition z
one (TZ), and total prostate gland volume were also determined by MR. Indiv
idual source strength ranged from 0.35 to 0.54 mu Gym(2)/h (NIST 99, median
0.46 mu Gym(2)/h) and the total implanted activity ranged from 17.0 to 43.
1 mCi (median, 28.1 mCi) using 43-120 seeds (median, 79). The seeds were pl
aced using MR-compatible biopsy needles (14-28, median, 19).
Results: The ability of clinical (MR defined prostate, PZ, and TZ volumes)
and technical (number of catheters, number of seeds implanted, and total ac
tivity) factors to predict AUR for 50 men undergoing MR-guided prostate int
erstitial brachytherapy were evaluated using univariable and logistic regre
ssion multivariable analyses. Six men (12%) experienced AUR within 24 h aft
er removal of the Foley catheter subsequent to prostate brachytherapy. The
total number of seeds (p = 0.05), MR determined prostate volume (p < 0.01),
and the MR-determined TZ volume (p < 0.01) were significant predictors of
AUR on univariable analysis. Utilizing a multivariable logistic regression
analysis, the TZ volume was the only significant predictor of AUR (p < 0.01
). The prostate volume is highly correlated to the TZ volume (Spearman corr
elation coefficient of 0.91) and was thus significant in the univariable an
alysis; however, the prostate volume did not add prognostic value in multiv
ariable analysis.
Conclusion: Benign prostatic hyperplasia (BPH) resulting in an enlarged TZ
volume, is the most important predictor of AUR following MR-guided prostate
interstitial radiation therapy. Although AUR was significant (60%) in men
with moderate BPH (TZ volume greater than or equal to 50 cc), it was also s
elf-limiting. (C) 2000 Elsevier Science Inc.